Biographies
Click the links below to jump to the full biographies.
Conference Directors
- Professor Rob Stockley
- Professor Sue Hill
Scientific Advisory Board Members
Professor A. G. N. Agustí
Hospital Universitario Son Dureta
Palma de Mallorca, Balearic Islands, SpainProfessor Alvar Agustí is currently Head of the Pulmonary Service at the University Hospital Son Dureta, Executive Director of the Fundación Caubet-Cimera and Scientific Director of the National Spanish Center for Respiratory Research (CIBER Enfermedade Respiatorias).
Professor Agustí’s main research interests include COPD and sleep disorders. He has published more than 200 papers and has over 30 contributions to books. He is regularly invited to speak at international conferences and symposia.
Professor Agustí is a member of several professional societies, including the American Thoracic Society, and the European Respiratory Society (ERS), in which he has been a Member of its Executive Committee. He is also member of the Royal Academy of Medicine of the Balearic Islands and Honorary Fellow of the Royal College of Physicians of Edinburgh (UK).
.
Angela Helen Evans
Specialist Practitioner (Respiratory), Stoke-On-Trent Primary Care Trust.
I am a Clinical Physiologist (Respiratory) and have been employed by a Primary Care Trust for the last two years. setting up an equitable spirometry service for the local patients.
In 2007 I recieved the Chief Scientific Officers award 'innovation in Health Improvement and Promotion' for this work. Prior to this I worked as a Clinical Physiologist (Respiratory) in the local acute trust for 29 years.
^ TOP
Dame Helena Shovelton
Chief Executive, British Lung Foundation
Helena Shovelton is currently Chief Executive of the British Lung Foundation. The only UK charity working to help people with all 43 lung diseases.
In this role she sits on the following groups; UK Lung Cancer Coalition, the Department of Health’s Lung Cancer & Mesothelioma Action Group, the Department of Health’s Physiological Measurement National Oversight Group. She is also a member of the External Reference Group for the COPD NSF and on a new working group attached to the End of Life Strategy Group. Helena also chairs the steering group for the Tobacco Control Coalition. She is also a non-executive Director of the Energy Saving Trust.
Previously Helena was Chair of the Audit Commission having been a Commissioner since 1995. She has also been a member of the Competition Commission for 7 years and a trustee for the RAF Benevolent Fund. Helena spent two years as a member of the Better Regulation Task Force and three years as Commissioner and then Deputy Chairman of the Local Government Commission for England and is a former member of the Banking Code Standards Board. Helena has also been Chair of the National Association of Citizens Advice Bureaux with a further four years as Vice Chair.
David Price
GPIAG Professor of Primary Care Respiratory Medicine, University of Aberdeen
David Price is extensively involved in primary care respiratory education and research. He also heads a research consortium of clinical care centers in the east of England.
His special areas of interest in primary care respiratory management are screening, “real-life” effectiveness and cost-effectiveness of interventions, compliance, and patient attitudes to their disease. He heads the research committees for the International Primary Care Respiratory Group. He does sessional work as a general practitioner and assists with the Norfolk wide respiratory GPwSI service.
Marc Decramer
Professor of Medicine and Chief of the Respiratory Division at the Katholieke Universiteit Leuven, Belgium
Marc Decramer is Professor of Medicine and Chief of the Respiratory Division at the Katholieke Universiteit Leuven, Belgium. He trained as a chest physician at the Katholieke Universiteit Leuven and McGill University, Montreal, Canada. He is board certified since 1984.
He serves on the Program Committee of the American Thoracic Society (ATS) Respiratory Structure and Function Assembly, and is former President of the Belgian Pneumology Association. Professor Decramer was the Editor of the European Respiratory Journal from 1999 till 2002, and is also reviewer for many other respected respiratory journals. He was Scientific Programme Committee Chairman of the European Respiratory Society (ERS) from 1995 till 1999.
Professor Decramer has authored over 200 academic papers in the field of respiratory disease, and presented widely at international symposia. His current research interests lie in the study of the respiratory and peripheral muscles in COPD patients. Further interests include exercise physiology, pharmacotherapy, and rehabilitation in patients with COPD.
^ TOP
Dr Rupert Jones
Clinical Research Fellow, Respiratory Research Unit, Peninsula Medical School, Plymouth, UK
Dr Jones leads the Respiratory Research Unit at the Peninsula Medical School. His research interests include psychological factors in COPD, pulmonary rehabilitation, education and self-management. He developed Lung Information Needs Questionnaire, LINQ, www.linq.org.uk, and an IT based system of assessment and management of patients with COPD according to guidelines.
^ TOP
Dr Steve Holmes
General Practitioner; Somerset (UK)
Steve has worked as a general practitioner since 1989. He has been chair of the General Practice Airways Group and worked with the British Thoracic Society, British Lung Foundation and Asthma UK as well as Royal Colleges and several UK universities on a variety of respiratory and medical education projects. He currently works part time in practice and part time at Somerset PCT.
^ TOP
E.F.M. Wouters, MD, PhD
University Hospital Maastricht, The Netherlands
Prof. Wouters studied medicine at the Catholic University of Leuven, Belgium, where he graduated in 1978. He was trained in internal medicine at the Annadal Hospital Maastricht and the University Hospital Leuven. In 1981, he started his residency at the Department of Respiratory Medicine of the University Hospital Maastricht and was registered as a pulmonologist in July 1984.
He received his Ph.D. for his thesis entitled “Bronchial response in COPD measured by forced oscillation technique” at the same University in 1987. After his appointment to Associate Professor of Pulmonology in 1988, he became Full Professor and chairman of the Department of Respiratory Medicine of the University Hospital Maastricht in 1992 and chairman of the board of CIRO Horn, a rehabilitation center for chronic diseases. He is currently involved in research into systemic manifestations of chronic inflammatory respiratory disorders.
He is chairman of the Advisory Council of the Dutch Asthma Foundation. He is director of the Centre for Chronic Diseases of the University Hospital Maastricht. He fulfils different memberships in scientific boards and task forces in Pulmonology. He published as (co)author more than 280 papers in scientific journals, largely related to COPD. At the moment he is member of the Editorial Board of the American Journal for Respiratory and Critical Care, Chest, Respiration, Monaldi Archives for Chest Disease, International Journal of Respiratory Care and Chronic Respiratory Disease.
^ TOP
Geertjan Wesseling MD PhD
Associate Professor of Respiratory Medicine, Maastricht University Medical Centre, The Netherlands
Geertjan Wesseling (1956) works at Maastricht University where his professional activities include patient care and disease management for patients with obstructive airways diseases and cystic fibrosis and research in these areas. Currently he chairs the asthma and COPD research programme of the Care and Public Health Research Institute (CAPHRI) in Maastricht.
^ TOP
Professor Jorgen Vestbo, DrMedSci FRCP
North West Lung Centre, Wythenshawe Hospital / University of Manchester, UK, and Department of Cardiology and Respiratory Medicine, Hvidovre Hospital / University of Copenhagen, Denmark.
Jørgen Vestbo is a specialist in internal medicine and respiratory medicine. His main research interests are clinical epidemiology and clinical research focused on COPD. JV was in the working group on the recently published ATS/ERS guidelines for COPD and is a member of the Science Committee of GOLD.
^ TOP
Dr M D L Morgan
Head of Service Dept of Respiratory Medicine, Allergy and Thoracic Surgery University Hospitals of Leicester Glenfield Hospital
Mike Morgan is a consultant respiratory physician and head of service at the Department of Respiratory Medicine, Allergy and Thoracic Surgery at the University Hospitals of Leicester NHS Trust at Glenfield Hospital. He has previously worked at Birmingham Heartlands and the Brompton Hospitals. His career interests have included the assessment and management of respiratory disability particularly in COPD.
He has published widely and was an author of the BTS and ERS/ATS statements on pulmonary rehabilitation. He is also a Council member and Vice president of the British Lung Foundation, the editor of Chronic Respiratory Disease and has recently retired as chairman of the Asthma UK research committee. He has just been elected as the UK delegate to the ERS
^ TOP
Paula M Meek RN Phd FAAN
Senior Associate Dean for Research, University of NM CON
Dr. Meek was a member of the ATS/ERS interdisciplinary team that developed the COPD statement and patient education materials. Her current investigation examines the role symptoms and cognitive function play in self-management of COPD.
^ TOP
Peter Barnes
Professor of Thoracic Medicine, National Heart & Lung Institute and Head of Respiratory Medicine, Imperial College London
Peter Barnes is Professor of Thoracic Medicine at the National Heart and Lung Institute, Head of Respiratory Medicine at Imperial College and Honorary Consultant Physician at Royal Brompton Hospital, London. He qualified at Cambridge and Oxford Universities was appointed to his present post in 1987.
He has published over 1000 peer-review papers on asthma, COPD and related topics and has edited over 40 books.
He is also amongst the top 50 most highly cited researchers in the world and has been the most highly cited clinical scientist in the UK and the most highly cites respiratory researcher in the world over the last 20 years. He is currently a member of the Scientific Committee of the WHO/NIH global guidelines on asthma (GINA) and COPD (GOLD). He also serves on the Editorial Board of over 30 journals and is currently an Associate Editor of Chest. He has given several prestigious lectures, including the Amberson Lecture at the American Thoracic Society and the Sadoul Lecture at the European Respiratory Society.
^ TOP
PMA Calverley
Professor of Respiratory Medicine, University of Liverpool; Honorary Consultant Physician , University Hospital Aintree
After graduating in Edinburgh and working there and in Montreal , Professor Calverley moved to Liverpool in 1985. He has published extensively on COPD and contributed to many international meetings and Guideline groups. He is a past President of the British Thoracic Society and currently chairs the Department of Health External Reference Group developing a National Service Framework for COPD care in England.
^ TOP
Leonardo M. Fabbri
Professor of Respiratory Medicine - Director Department of Respiratory Diseases University of Modena & Reggio Emilia Via del Pozzo 71,I-41100 MODENA - Italy
LMF is Professor of Respiratory Medicine and Director of the Section of Respiratory Diseases of the Department of Medicine of the University of Modena and Reggio Emilia.
He leads a multicenter research group at the Universities of Modena, Ferrara and Padua on the role of inflammation in asthma and chronic obstructive pulmonary diseases. He is President Elect of the ERS.
^ TOP
Professor Sherwood Burge
Consultant Physician, Heart of England NHS Foundation Trust
I became interested in COPD in 1980 and I was overwhelmed by the number of patients with COPD. At that time, a trial of steroids was recommended. The methods of evaluating this were unclear.
Over the next 15 years, I did a series of short term trials of oral and inhaled steroids concluding that the response was unimodally distributed. Factors related to good steroid response were a recent deterioration immediately before the steroid trial and that there was a clear regression towards the mean effect.
High dose inhaled steroids performed as well as oral steroids but took slightly longer to reach their peak and that any response to oral or inhaled steroids were not predictive of future benefit or lack of benefit in long term use.
Then followed a series of studies of inhaled corticosteroids in an attempt to show limitation of disease progression using FEV1 decline as the outcome perimeter. I still believe that FEV1 decline is a useful outcome measure but it needs to be started over longer periods of time. It is much easier to show benefit in terms of exacerbation prevention, minor improvements in short term spirometry and quality of life and to show changes in FEV1 decline. I believe that the main way forward is to apply what we know much more generally, to identify disease earlier and to have good quality multi-disciplinary team working, aiming predominantly to limit disease progression. This is the focus of current work.
I am also interested in non smoking related causes of COPD, particularly those found in the work place. I have done studies of silica and ceramic fibre exposure in particular. However, I believe that there has been major improvements in the management of COPD over the last 20 years by putting together a lot of factors which on their own produce small benefit similar to the achievements that have been made in Cardiology.
Cold housing and poor clothing are under-researched factors related to poor outcomes in COPD.
^ TOP
Professor William MacNee
ELEGI Colt Laboratory MRC/uoE Centre for Inflammation Research Level 2, The Queen’s Medical Research Institute
Professor William MacNee is Professor of Respiratory and Environmental Medicine, University of Edinburgh and Honorary Consultant Physician in the Royal Infirmary of Edinburgh.
He is President of the European Respiratory Society. Professor MacNee was elected President of the European Society for 2006-2007. His research interests involve the study of aspects of the inflammation in patients with chronic obstructive pulmonary disease and particularly the cell and molecular mechanisms of the balance between oxidants and antioxidants in the lungs. He has developed an interest in the processes by which the lungs deal with inhaled toxic substances especially air pollutants.
He has published over 230 original scientific papers, chapters and reviews and is editor or co-editor of several books. He has lectured on the topics of chronic obstructive pulmonary disease and air pollution throughout the world.
^ TOP
R Rodriguez-Roisin, MD, FRCPE
Professor of Medicine, Academic Affairs Director & Senior Consultant Physician. Hospital Clínic, Universitat de Barcelona .
ROBERTO RODRIGUEZ-ROISIN is Professor of Medicine, Chair, at the Universitat de Barcelona and Senior Consultant Physician of the Service of Respiratory Medicine at the Hospital Clínic in Barcelona, Spain. He received the M.D. degree (1970) and the Ph.D. degree (1975) from the same University de Barcelona. His areas of major interest are the pathophysiology and pathobiology of chronic obstructive airway diseases.
^ TOP
Robert O Crapo, M.D.
Professor of Medicine at the University of and Medical Director of the Pulmonary Lab at LDS Hospital in Salt Lake City
Robert O. Crapo is a Professor of Medicine at the University of and Medical Director of the Pulmonary Lab at LDS Hospital in Salt Lake City, Utah where his primary interests are in pulmonary function testing and the diagnosis and treatment of obstructive lung diseases.
He is a graduate of the University of Rochester School of Medicine. Dr. Crapo serves on the National Heart Lung and Blood Institute’s Asthma Clinical Research Network Protocol Review Committee. He has been a member of the American Thoracic Society Committee on Proficiency Standards for Clinical Pulmonary Laboratories since 1983 and has chaired the committee since 1993. The committee has recently published international standards for pulmonary function testing in collaboration with the European Respiratory Society.
The independent testing laboratory at LDS Hospital tests most pulmonary function instruments for accuracy and precision before they come to market. He provides teaching and quality control oversight for pulmonary function tests performed as part of NHLBI and pharmaceutical company studies. He has also served as member of the Asthma Clinical Research Network's protocol review committee. Publications include 115 original manuscripts, 16 reviews, and 19 monographs or book chapters. More importantly, he is married to Susan Edman Crapo. We have four children and two delightful grandchildren.
^ TOP
Samantha Prigmore RGN, MSc, BSc (Hons)
Respiratory Nurse Consultant St George’s Healthcare NHS Trust
Sam qualified in Oxford in 1987 and pursued her career in cardiothoracic nursing, through undertaking the ENB 249 at the Brompton Hospital, before moving to St George’s Healthcare Trust in 1990, where she worked on a cardiothoracic surgical ward and then as ward sister on a respiratory medical ward in 1991. She was involved in the creation of one the first respiratory nurse specialist posts, taking up the position in 1993 and appointed to nurse consultant in 2003.
She has worked closely with local primary care trusts merging traditional primary and secondary care boundaries, to provide seamless care for respiratory patients from diagnosis through to end stage disease. She is also a lecturer at Imperial College/ Royal Brompton Hospital for the MSc Cardio-Respiratory Nursing and Cardio-Respiratory Critical Care Courses, leading the respiratory module.
She has a special interest in self management in respiratory conditions and palliative care.
She is Chair for the Association of Respiratory Nurses, represents nursing on the External Reference Group for the COPD NSF, Trustee for the British Lung Foundation and has been a committee member of the British Thoracic Society Professional Standards and Tobacco Committees.
^ TOP
Dr. Sonia Buist
Professor of Medicine at the Oregon Health & Science University in Portland, Oregon, USA.
Dr. Sonia Buist is currently Professor of Medicine at the Oregon Health & Science University in Portland, Oregon, USA. She is presently Chair of the Global Initiative on Chronic Obstructive Lung Disease (GOLD). She has held numerous positions in the American Thoracic Society and was President in 1990-91.
^ TOP
Wiesia Wedzivha
Professor of Respiratory Medicine at the Royal Free and University College Medical School, University College London
Wisia Wedzicha is Professor of Respiratory Medicine at the Royal Free and University College Medical School, University College London. She qualified from Oxford University and St Bartholomew’s Hospital Medical College.
She has a major interest in the causes, mechanisms and impact of COPD exacerbations and has published extensively on this topic. She also is an expert on home ventilatory support in COPD patients and is currently the Chair of the British Thoracic Society working group on the home oxygen therapy and a member of the Department of Health’s External Stakeholders Advisory Group for the Home Oxygen Service. He was a member of the Guideline Development Group for the NICE COPD guidelines. She is currently Editor in Chief of the respiratory journal Thorax and on the Editorial Board of AJRCCM.
^ TOP